Peterlabs Holdings Bhd (XKLS:0171) Net-Net Working Capital: RM0.02 (As of Jun. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

XKLS:0171 Peterlabs Holdings Bhd XKLS:0171
47 GF Score
Price RM0.22
View Full Analysis

What is Peterlabs Holdings Bhd Net-Net Working Capital?

Peterlabs Holdings Bhd XKLS:0171 +2.38% 47 Net-Net Working Capital is RM0.02 as of Jun. 2025. GuruFocus rates XKLS:0171 with a GF Score™ of 47/100.

In calculating the Net-Net Working Capital (NNWC), Benjamin Graham assumed that a company's accounts receivable is only worth 75% its value, its inventory is only worth 50% of its value, but its liabilities have to be paid in full. In addition, Graham believed that preferred stock belongs on the liability side of the balance sheet, not as part of capital and surplus. This is a conservative way of estimating the company's value.

Peterlabs Holdings Bhd's Net-Net Working Capital for the quarter that ended in Jun. 2025 was RM0.02.

The industry rank for Peterlabs Holdings Bhd's Net-Net Working Capital or its related term are showing as below:

XKLS:0171's Price-to-Net-Net-Working-Capital is not ranked *
in the Drug Manufacturers industry.
Industry Median: 7.89
* Ranked among companies with meaningful Price-to-Net-Net-Working-Capital only.

Peterlabs Holdings Bhd  (XKLS:0171) Net-Net Working Capital Explanation

One research study, covering the years 1970 through 1983 showed that portfolios picked at the beginning of each year, and held for one year, returned 29.4 percent, on average, over the 13-year period, compared to 11.5 percent for the S&P 500 Index. Other studies of Graham's strategy produced similar results.

Benjamin Graham looked for companies whose market values were less than two-thirds of their net-net value. They are collected under our Net-Net screener.


Peterlabs Holdings Bhd Net-Net Working Capital Related Terms


Peterlabs Holdings Bhd Net-Net Working Capital Historical Data

* Premium members only.

The historical data trend for Peterlabs Holdings Bhd's Net-Net Working Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Peterlabs Holdings Bhd Net-Net Working Capital Chart

Peterlabs Holdings Bhd Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Net-Net Working Capital
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.10 0.13 0.06 0.06 0.04

Peterlabs Holdings Bhd Quarterly Data
Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25
Net-Net Working Capital Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.04 0.04 0.02 0.04 0.02

XKLS:0171 vs ZTS, UTHR, VTRS: Net-Net Working Capital Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Peterlabs Holdings Bhd's Price-to-Net-Net-Working-Capital, along with its competitors' market caps and Price-to-Net-Net-Working-Capital data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Peterlabs Holdings Bhd Price-to-Net-Net-Working-Capital vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Peterlabs Holdings Bhd's Price-to-Net-Net-Working-Capital distribution charts can be found below:

* The bar in red indicates where Peterlabs Holdings Bhd's Price-to-Net-Net-Working-Capital falls into.


XKLS:0171
47GF Score
Peterlabs Holdings Bhd XKLS:0171
Net-Net Working Capital is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Peterlabs Holdings Bhd Net-Net Working Capital Calculation

Peterlabs Holdings Bhd's Net-Net Working Capital (NNWC) per share for the fiscal year that ended in Dec. 2023 is calculated as

Net-Net Working Capital(A: Dec. 2023 )
=(Cash, Cash Equivalents, Marketable Securities+0.75 * Accounts Receivable+0.5 * Total Inventories-Total Liabilities
-Preferred Stock-Minority Interest)/Shares Outstanding (EOP)
=(16.102+0.75 * 32.538+0.5 * 22.356-37.992
-0-2.588)/275.214
=0.04

Peterlabs Holdings Bhd's Net-Net Working Capital (NNWC) per share for the quarter that ended in Jun. 2025 is calculated as

Net-Net Working Capital(Q: Jun. 2025 )
=(Cash, Cash Equivalents, Marketable Securities+0.75 * Accounts Receivable+0.5 * Total Inventories-Total Liabilities
-Preferred Stock-Minority Interest)/Shares Outstanding (EOP)
=(10.558+0.75 * 24.17+0.5 * 22.585-34.905
-0-0.362)/275.214
=0.02

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In calculating the Net-Net Working Capital (NNWC), Benjamin Graham assumed that a company's accounts receivable is only worth 75% its value, its inventory is only worth 50% of its value, but its liabilities have to be paid in full.

In addition, Graham believed that preferred stock belongs on the liability side of the balance sheet, not as part of capital and surplus. In "Security Analysis", preferred stock is dubbed "an imperfect creditorship position" that is best placed on the balance sheet alongside funded debt.

This is a conservative way of estimating the company's value.

What does a Net-Net Working Capital of RM0.02 mean?
Peterlabs Holdings Bhd (XKLS:0171) has a Net-Net Working Capital of RM0.02 as of Jun. 2025. Ben Graham defined net-net working capital as the per-share sum of cash, 75% of receivables and 50% of inventory less total liabilities. View historical data on Peterlabs Holdings Bhd
Is Peterlabs Holdings Bhd's Net-Net Working Capital too high?
Peterlabs Holdings Bhd's current Net-Net Working Capital is RM0.02. Overall, Peterlabs Holdings Bhd has a GF Score™ of 47/100, reflecting its overall financial health beyond just this single metric.
How does Peterlabs Holdings Bhd's Net-Net Working Capital compare to ZTS and UTHR?
Peterlabs Holdings Bhd's Net-Net Working Capital of RM0.02 can be compared against companies in the Drug Manufacturers industry. The industry median Net-Net Working Capital is 7.89. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net-Net Working Capital for a Drug Manufacturers company?
The median Net-Net Working Capital among Drug Manufacturers companies is 7.89, based on 409 companies in the industry. Companies in the top quartile (top 25%) have a Net-Net Working Capital significantly above this median, while those in the bottom quartile fall well below. However, Net-Net Working Capital should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net-Net Working Capital mean?
A high Net-Net Working Capital can signal that a stock is expensive relative to its fundamentals. Ben Graham defined net-net working capital as the per-share sum of cash, 75% of receivables and 50% of inventory less total liabilities. View historical data on Peterlabs Holdings Bhd For the Drug Manufacturers industry, the median Net-Net Working Capital is 7.89 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Peterlabs Holdings Bhd's current Net-Net Working Capital is RM0.02. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Peterlabs Holdings Bhd stock overvalued right now?
Peterlabs Holdings Bhd (XKLS:0171) has a current Net-Net Working Capital of RM0.02. The current Net-Net Working Capital is RM0.02. Peterlabs Holdings Bhd's overall GF Score™ is 47/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net-Net Working Capital calculated?
Net-Net Working Capital is calculated from a company's financial statements. For Peterlabs Holdings Bhd (XKLS:0171), the current Net-Net Working Capital is RM0.02 as of Jun. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Peterlabs Holdings Bhd Business Description

Address Jalan Nilam 3, Lot 16014 (PT No. 24341), Bandar Nilai Utama, Nilai, NSN, MYS, 71800
Peterlabs Holdings Bhd is engaged in the manufacturing, distribution, export, and trading of animal health and nutrition products. The Group offers biosecurity and disinfectants, compound feed supplements, feed additives, nutritional premixes, pharmaceuticals, and water-soluble supplements, as well as farm management, technical advisory services, raw material analysis, and feed formulation. Its segments are Manufacturing, which covers the manufacturing and distribution of animal health and nutrition products; Trading, which involves the trading and distribution of animal health and nutrition products and consumer goods, and contributes the majority of its revenue; and Others, which provides investment holding services. The company operates in Malaysia and internationally.
47GF Score

Get the complete analysis for XKLS:0171

Net-Net Working Capital is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

RM0.22
Price